Viking Emerges As Obesity Contender With Strong Phase II Readout

 
• By Joseph Haas
  
Obesity medication
Viking's Phase II obesity data look competitive in a busy therapeutic space • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D